|
DENGUE THE DEADLY KILLER
TABLE OF
CONTENTS:
Dengue and
Dengue Haemorrhagic Fever
Dengue Fever
Mosquitoes and the Diseases They Can Carry
Civil Society at
its Best: Dengue Awareness Campaigne in City
DENGUE
AND DENGUE HAEMORRHAGIC FEVER
Dengue is a mosquito-borne
infection which in recent years has become a major international
public health concern. Dengue is found in tropical and
sub-tropical regions around the world, predominately in urban
and peri-urban areas. Dengue haemorrhagic fever (DHF), a
potentially lethal complication, was first recognized during the
1950s and is today a leading cause of childhood mortality in
several Asian countries. There are four distinct, but closely
related, viruses which cause dengue. Recovery from infection by
one provides lifelong immunity against that serotype but confers
only partial and transient protection against subsequent
infection by the other three. Indeed, there is good evidence
that sequential infection increases the risk of more serious
disease resulting in DHF.
Prevalence
The global prevalence of
dengue has grown dramatically in recent decades. The disease is
now endemic in more than 100 countries in Africa, the Americas,
the Eastern Mediterranean, South-East Asia and the Western
Pacific (see Table 1). South-East Asia and the Western Pacific
are most seriously affected. Before 1970 only nine countries had
experienced DHF epidemics, a number which had increased more
than four-fold by 1995. Some 2500 million people � two fifths of
the world's population - are now at risk from dengue. WHO
currently estimates there may be 50 million cases of dengue
infection worldwide every year. In 1998 alone, there were more
than 616,000 cases of dengue in the Americas, of which 11,000
cases were DHF. This is greater than double the number of dengue
cases which were recorded in the same region in 1995. Not only
is the number of cases increasing as the disease is spreading to
new areas, but explosive outbreaks are occurring. In Brazil
nearly 475,000 cases were reported between January and October
1998 � more than were reported from the entire continent in
previous years.
Some other statistics:
-
During epidemics of
dengue, attack rates among susceptibles are often 40 � 50%,
but may reach 80 � 90%.
-
An estimated 500 000
cases of DHF require hospitalisation each year, of whom a very
large proportion are children and roughly 5% die.
-
Without proper
treatment, DHF case fatality rates can exceed 20%. With modern
intensive supportive therapy, the rate can be reduced to less
than 1%.
The spread of dengue is attributed to expanding geographic
distribution of the four dengue viruses and of their mosquito
vectors, the most important of which is the predominantly
urban species Aedes aegypti. A rapid rise in urban population
is bringing ever greater numbers of people into contact with
this vector, especially in areas which are favourable for
mosquito breeding e.g., where household water storage is
common and where solid waste disposal services are inadequate.
Transmission
Dengue viruses are
transmitted to humans through the bites of infective female
Aedes mosquitoes. Mosquitoes generally acquire the virus while
feeding on the blood of an infected person. Once infective a
mosquito is capable of transmitting the virus to susceptible
individuals for the rest of its life, during probing and blood
feeding. Infected femalemosquitoes may also transmit the virus
to the next generation of mosquitoes by transovarial
transmission i.e. via its eggs, but the role of this in
sustaining transmission of virus to humans has not yet been
delineated. Humans are the main amplifying host of the virus,
although studies have shown that in some parts of the world
monkeys may become infected and perhaps serve as a source of
virus for uninfected mosquitoes. The virus circulates in the
blood of infected humans for 2-7 days, at approximately the same
time as they have fever; Aedes mosquitoes may acquire the virus
when they feed on an individual at this time.
Characteristics
Dengue fever is a severe,
flu-like illness that affects infants, young children and adults
but rarely causes death. The clinical features of dengue fever
vary according to the age of the patient. Infants and young
children may have a non-specific febrile illness with rash.
Older children and adults may have either a mild febrile
syndrome or the classical incapacitating disease with abrupt
onset and high fever, severe headache, pain behind the eyes,
muscle and joint pains, and rash. Dengue haemorrhagic fever is a
potentially deadly complication that is characterized by high
fever, haemorrhagic phenomena�often with enlargement of the
liver�and in severe cases, circulatory failure. The illness
commonly begins with a sudden rise in temperature accompanied by
facial flush and other non-specific constitutional symptoms of
dengue fever. The fever usually continues for 2-7 days and can
be as high as 40-41� C, possibly with febrile convulsions and
haemorrhagic phenomena. In moderate DHF cases, all signs and
symptoms abate after the fever subsides. In severe cases, the
patient's condition may suddenly deteriorate after a few days of
fever; the temperature drops, followed by signs of circulatory
failure, and the patient may rapidly go into a critical state of
shock and die within 12-24 hours, or quickly recover following
appropriate volume replacement therapy.
Treatment
There is no specific
treatment for dengue fever. However, careful clinical management
by experienced physicians and nurses frequently save the lives
of DHF patients. With appropriate intensive supportive therapy,
mortality may be reduced to less than 1%. Maintenance of the
circulating fluid volume is the central feature of DHF case
management.
Immunization
Vaccine development for
dengue and DHF is difficult because any of four different
viruses may cause disease, and because protection against only
one or two dengue viruses could actually increase the risk of
more serious disease. Nonetheless, progress is gradually being
made in the development of vaccines that may protect against all
four dengue viruses. Such products could be commercially
available within several years.
Prevention and Control
At present, the only
method of controlling or preventing dengue and DHF is to combat
the vector mosquitoes. In Asia and the Americas, Aedes aegypti
breeds primarily in man-made containers like earthenware jars,
metal drums and concrete cisterns used for domestic water
storage, as well as discarded plastic food containers, used
automobile tyres and other items that collect rainwater In
Africa it also breeds extensively in natural habitats such as
tree holes and leaf axils. In recent years, Aedes albopictus, a
secondary dengue vector in Asia, has become established in the
United States and several Latin American and Caribbean countries
as well as two European and one African state. The rapid
geographic spread of this species has been largely attributed to
the international trade in used tyres. Vector control is
implemented using environmental management and chemical methods.
Proper solid waste disposal and improved water storage
practices, including covering containers to prevent access by
egg laying female mosquitoes are among methods which are
encouraged through community-based programmes. The application
of appropriate insecticides to larval habitats, particularly
those which are considered useful by the householders, e.g.
water storage vessels, prevent mosquito breeding for several
weeks but must be re-applied periodically. Small,
mosquito-eating fish have also been used with some success.
During outbreaks, emergency control measures may also include
the application of insecticides as space sprays to kill adult
mosquitoes using portable or truck-mounted machines or even
aircraft.
However, the killing
effect is only transient, variable in its effectiveness because
the aerosol droplets may not penetrate indoors to microhabitats
where adult mosquitoes are sequestered, and the procedure is
costly and operationally very demanding. Regular monitoring of
the vectors' susceptibility to the most widely used insecticides
is necessary to ensure the appropriate choice of chemicals.
Active monitoring and surveillance of the natural mosquito
population should accompany control efforts in order to
determine the impact of the programme
Source: WHO Press Releases, Fact Sheets and Features
http://www.who.ch
TOP
DENGUE FEVER
INTRODUCTION
Dengue fever virus is
considered the most important arbovirus in terms of morbidity,
mortality and economic cost with an estimated 100 million cases
of dengue fever occurring throughout the world annually. Dengue
is transmitted by mosquito and occurs in epidemic and endemic
proportions throughout tropical and subtropical regions of the
world. Infection with dengue virus causes a wide number of
clinical symptoms which range in severity. These include fever,
a maculopapular rash and headache. Primary infection with dengue
usually results in a febrile, self limiting disease, however,
secondary infection may result in severe complications such as
dengue shock syndrome (DSS) or dengue haemorrhagic fever (DHF).
Patients diagnosed with dengue in endemic areas such as South
East Asia generally have secondary infection, whereas patients
in non endemic areas are usually diagnosed with primary
infection. Characteristic antibody responses to the disease
enable serological diagnosis and differentiation between primary
and secondary dengue.
MORPHOLOGY
RNA viruses belong to
family Flaviviridae four serotypes (1, 2, 3 and 4) different
strains within each serotype
PATHOGENESIS
Transmitted by mosquito,
principally Aedes aegypti
incubation time ranges from 3 to 10 days
CLINICAL ASPECTS
Primary Infection acute
febrile illness of sudden onset fever lasting 3 to 5 days
headache, myalgia, arthralgia or muscular pain, retro-orbital
pain, anorexia fine mculopapular rash on extremities recovery
may be associated with fatigue and depression chidren usually
have milder disease than adults
Secondary Infection
Over 90% of cases of DHF
and DSS occur in patients previously infected with the virus
symptoms are similar to those seen in primary infection,
although after a period of 3 to 7 days the patient goes on to
display
Haemorrhagic symptoms
Bleeding, particularly in
skin (petichiae), occaisionally in gunms and nose increased
vascular permeability, resulting in leakage of plasma into
extravascular spaces and which leads to hypovolaemia
haemorrhagic symptoms reduced blood pressure vascular changes
and coagulopathy circulatory shock vomiting and abdominal pain
lymphadenopathy and hepatomegaly may occur presence of blood in
stools, vomitus, urine
ANTIBODY RESPONSE
Infection will result in
lifelong immunity to that serotype, but only temporary immunity
to other serotypes
Primary Infection
-
IgM antibodies appear
approximately 5 days after onset of symptoms and rise for the
next 1-3 weeks
-
IgM antibodies
detectable for up to 6 months
-
IgG are detectable at
approximately 14 days after onset of symptoms and are
maintained for life
Secondary Infection
Approximately 5% patients
do not produce detectable levels of specific IgM
-
IgM titre can be slower
to rise in secondary infection
-
IgG appears
approximately 2 days after symptoms appear
-
IgG titre significantly
higher in secondary infection
DIAGNOSIS
May not be diagnosed
correctly in endemic areas due to generalised and non specific
clinical manifestations based mainly on serological methods, as
this method is useful in distinguishing primary from secondary
infection
Haemagglutination
Inhibition Assays (HAI)
Traditional method of
diagnosis sera must be acetone or kaolin treated before testing
requires paired sera collected at least 7 days apart variance in
potency of haemagglutinins made in different laboratories has
lead to doubts regarding general applicability
ELISA
Pre-treatment of sera is
not required serial dilution not required - diagnosis can be
made from a single serum specimen diagnosis can be from a single
serum sample
TREATMENT
No Specific treatment for
primary dengue Secondary Infection intravenous fluid replacement
and use of plasma expanders oxygen therapy blood transfusions in
cases of severe bleeding heparin for severe haemorrhage
PREVENTION
Presently no vaccine for
prevention of disease interruption of breeding cycles of
mosquitoes, particularly in stagnant water around the home use
of insect repellent and insecticidal treatment and spraying.
Source:
PanBio Pty. Ltd.,
Brisbane, Australia.
http://www.panbio.com.au/lit.htm
TOP
MOSQUITOES AND THE DISEASES
THEY CAN CARRY
Almost everyone has had
the unpleasant experience of being bitten by a mosquito.
Mosquito bites can cause severe skin irritation through an
allergic reaction to the mosquito's saliva - this is what causes
the red bump and itching. But a more serious consequence of some
mosquito bites may be transmission of certain serious diseases
such as malaria, dengue fever and several forms of encephalitis.
Not only can mosquitoes carry diseases which afflict humans, but
they also can transmit several diseases and parasites that dogs
and horses are very susceptible to. These include dog heart
worms and eastern equine encephalitis.
Aedes
Aegypti the Dengue Vector
There are about 200
different species of mosquitoes in the United States, all of
which live in specific habitats, exhibit unique behaviors and
bite different types of animals. Despite these differences, all
mosquitoes share some common traits, such as a four-stage life
cycle. After the female mosquito obtains a blood meal (male
mosquitoes do not bite), she lays her eggs directly on the
surface of stagnant water, in a depression, or on the edge of a
container where rainwater may collect and flood the eggs. The
eggs hatch and a mosquito larva or "wriggler" emerges. The larva
lives in the water, feeds and develops into the third stage of
the life cycle called a pupa or "tumbler". The pupa also lives
in the water, but no longer feeds. Finally, the mosquito emerges
from the pupal case and the water as a fully developed adult,
ready to bite.
Mosquito Life Cycle
The type of standing water
in which the mosquito chooses to lay her eggs depends upon the
species. The presence of beneficial predators such as fish and
dragonfly nymphs in permanent ponds, lakes and streams usually
keep these bodies of water relatively free of mosquito larvae.
However, portions of marshes, swamps, clogged ditches and
temporary pools and puddles are all prolific mosquito breeding
sites. Other sites in which some species lay their eggs include
tree holes and containers such as old tires, buckets, toys,
potted plant trays and saucers and plastic covers or tarpaulins.
Some of the most annoying and potentially dangerous mosquito
species, such as the Asian tiger mosquito, come from these
sites.
What You Can Do to Help
Fight Mosquitoes
-
Empty standing water in
old tires, cemetery urns, buckets, plastic covers, toys, or
any other container where "wrigglers" and "tumblers" live.
-
Empty and change the
water in bird baths, fountains, wading pools, rain barrels,
and potted plant trays at least once a week if not more often.
-
Drain or fill temporary
pools with dirt.
-
Keep swimming pools
treated and circulating and rain gutters unclogged.
-
Use mosquito repellents
when necessary and follow label directions and precautions
closely.
-
Use head nets, long
sleeves and long pants if you venture into areas with high
mosquito populations, such as salt marshes.
-
If there is a
mosquito-borne disease warning in effect, stay inside during
the evening when mosquitoes are most active.
-
Make sure window and
door screens are "bug tight."
-
Replace your outdoor
lights with yellow "bug" lights.
-
Contact your local
mosquito control district or health department.
Source: American Mosquito Control Association (AMCA) (a
member of the EPA Pesticide Environmental Stewardship Program (PESP))
http://www.epa.gov/pesticides/citizens/mosquito.htm
TOP
CIVIL SOCIETY AT ITS BEST:
DENGUE AWARENESS CAMPAIGNE IN DHAKA CITY
Awareness campaigne about Dengue infection and its prevention
led by Prof. Abdullah Abu Sayeed, president of Bishwa Shahittya
Kendra
A citizens body led by
president of Bishwa Shahittya Kendra, Prof. Abdullah Abu Sayeed,
yesterday launched an awareness campaigne in the capital about
dengue infection and its prevention.
According to a press
release a group of artists including magician Jewel Aich, TV and
stage performer Khairul Alam Sabuj, actress Shirin Bakul and
economist Prof. Anisur Rahman and Dr. Atiur Rahman took part in
the campaigne.
The group boarding a
vehicle distributed leaflets at different points of the city.
There were festoons and banners on the the vehicle with various
information on the dreaded disease.
Members of the groups
sprayed insecticide in some areas and appealed to people to join
the campaign to continue for seven days.
They went to different
educational institutions including Dhaka college Notre Dame
College and Ideal College and encouraged students to begin a
civil society movement against Dengue fever.
Source:
The
Daily Star http://www.dailystarnews.com
Disclaimer:
All information shown here are from different sources. The SDNP
is not responsible for any inaccuracy in them.
TOP |